These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2678934

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Combination chemotherapy of advanced bladder cancer].
    Kiyohara H.
    Hinyokika Kiyo; 1986 Dec; 32(12):1925-30. PubMed ID: 3825829
    [Abstract] [Full Text] [Related]

  • 4. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
    Yoshida O, Kakehi Y, Arai Y, Tomoyoshi T, Okada Y, Matsuda T, Mikami O, Fukuyama T, Hida S, Okabe T.
    Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
    [Abstract] [Full Text] [Related]

  • 5. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 6. [Combination chemotherapy of cyclophosphamide, adriamycin and cisplatin in advanced urothelial cancer].
    Nakagawa S, Nakao M, Toyoda K, Nukui M, Takada H, Ebisui K, Watanabe H, Furusawa T, Maegawa M, Kaiho H.
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3071-7. PubMed ID: 3674892
    [Abstract] [Full Text] [Related]

  • 7. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
    Uekado Y, Ogawa T, Yoshida T, Yamamoto S, Hirano A, Watanabe T, Shinka T, Ohkawa T.
    Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
    [Abstract] [Full Text] [Related]

  • 8. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T, Hida S, Ooishi K, Okada K, Yoshida O.
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [Abstract] [Full Text] [Related]

  • 9. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.
    Lin CC, Hsu CH, Huang CY, Cheng AL, Vogelzang NJ, Pu YS.
    J Urol; 2007 Jan; 177(1):84-9; discussion 89. PubMed ID: 17162009
    [Abstract] [Full Text] [Related]

  • 10. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder.
    Poortmans PM, Richaud P, Collette L, Ho Goey S, Pierart M, Van Der Hulst M, Bolla M, EORTC Radiation Oncology Group.
    Acta Oncol; 2008 Jan; 47(5):937-40. PubMed ID: 18568488
    [Abstract] [Full Text] [Related]

  • 11. [Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity].
    Rassweiler J, Rüther U, Bäuerle K, Bub P, Jipp P, Eisenberger F.
    Urologe A; 1989 Jan; 28(1):25-30. PubMed ID: 2922897
    [Abstract] [Full Text] [Related]

  • 12. [Therapeutic experiences of cis-diamminedichloroplatinum, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer].
    Ogawa O, Yoshimura N, Taniguchi T, Nishimura K, Nakagawa T.
    Hinyokika Kiyo; 1986 Jun; 32(6):795-802. PubMed ID: 3766338
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 14. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
    Balbay MD, Ozen H, Uluçay S, Sahin A, Ergen A, Koçal C, Remzi D.
    Int Urol Nephrol; 1993 Sep; 25(4):351-7. PubMed ID: 8276565
    [Abstract] [Full Text] [Related]

  • 15. Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.
    Sulkes A, Fuks Z.
    Cancer Treat Rep; 1983 Feb; 67(2):200-1. PubMed ID: 6681734
    [No Abstract] [Full Text] [Related]

  • 16. [Intraarterial chemotherapy with bladder preservation in patients with invasive bladder carcinoma].
    Shiba M, Takatera H, Fujii T, Tokizane T, Shimizu K, Tushima J.
    Hinyokika Kiyo; 2004 Jan; 50(1):15-9. PubMed ID: 15032009
    [Abstract] [Full Text] [Related]

  • 17. [Intra-arterial chemotherapy of patients in the late stages of bladder cancer].
    Dunchik VN, Drozdovskiĭ BIa, Kariakin OB, Grishin GN.
    Urol Nefrol (Mosk); 1985 Jan; (2):19-23. PubMed ID: 3992752
    [No Abstract] [Full Text] [Related]

  • 18. [Preliminary results of prophylactic adjuvant chemotherapy with CISCA in bladder tumors].
    Bittard H.
    J Urol (Paris); 1988 Jan; 94(7):345-7. PubMed ID: 2464650
    [Abstract] [Full Text] [Related]

  • 19. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
    Martínez-Piñeiro JA, de la Peña JJ, Hidalgo L, Cisneros J, Jiménez de León J, Machuca J.
    Arch Esp Urol; 1986 Jan; 39(1):33-46. PubMed ID: 3707210
    [No Abstract] [Full Text] [Related]

  • 20. [Combination chemotherapy with cisplatin, ifosfamide and adriamycin in patients with advanced transitional cell carcinoma of the urinary tract].
    Yoshimoto J, Nasu Y, Akagi T, Obama T, Tsushima T, Ozaki Y, Matsumura Y, Ohmori H, Asahi T, Ohkita K.
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1312-7. PubMed ID: 4039919
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.